JMP Securities Reaffirms Their Buy Rating on Blueprint Medicines (BPMC)
JMP Securities analyst Reni Benjamin maintained a Buy rating on Blueprint Medicines (BPMC – Research Report) today and set a price target of ...
JMP Securities Reaffirms Their Buy Rating on Kemper (KMPR)
JMP Securities analyst Matthew Carletti reiterated a Buy rating on Kemper (KMPR – Research Report) today and set a price target of $85.00. The ...
JMP Securities Raises Axon Enterprise, Inc. (AXON) Price Target to $725 on AI & Defense Demand
We recently compiled a list of the 8 AI Stocks on Investors’ Radar. In this article, we are going to take a look at where ...
JMP Securities holds Snap stock at $16 target, cites strong 4Q24
JMP Securities maintained a bullish stance on Snap Inc (NYSE: NYSE:SNAP), reiterating their Market Outperform rating with a $16.00 price target. The endorsement follows Snap's release of its ...
Why Pharvaris (PHVS) Is Advancing Today
Pharvaris (PHVS) is climbing 3% after investment bank JMP Securities raised its price target on the shares to $55, based on ...
Meta's AI Investments, Llama Expansion, Ad Tech Growth Earn Analyst Conviction
Meta Platforms, Inc (NASDAQ:META) stock is trading higher after multiple firms raised their price forecasts on the stock ...